Metaraminol Infusion Rate
Metaraminol is typically infused at 1-6 mg/hour (approximately 15-100 mcg/min) in critically ill patients, with most patients requiring doses in the lower range of 1-2 mg/hour.
Standard Dosing Parameters
Based on the most recent clinical evidence, metaraminol infusion follows these parameters:
- Initial rate: 1-2 mg/hour (15-30 mcg/min) 1
- Typical range: 1-6 mg/hour (15-100 mcg/min) 1
- Median duration: 10 hours (IQR 3-24 hours) 1
Concentration and Administration
The standard preparation uses:
- Concentration: 0.02 mg/mL (20 mcg/mL)
- Fixed infusion rate: 100 mL/hour 2
- This delivers 2 mg/hour at baseline
Clinical Context and Adjustments
For Cesarean Section (Spinal Anesthesia)
The ED50 for preventing post-spinal hypotension varies by maternal BMI:
- Standard BMI (<30 kg/m²): 1.84 mg/hour (95% CI: 1.76-1.89 mg/h) 2
- Obese patients (BMI ≥30 kg/m²): 2.28 mg/hour (95% CI: 2.19-2.43 mg/h) 2
The obese group requires approximately 24% higher doses. Adjust the prophylactic dose upward for obese parturients to maintain adequate blood pressure control.
For ICU Patients
In the intensive care setting, dosing is generally conservative 1:
- Most patients receive 1-2 mg/hour initially
- Doses rarely exceed 6 mg/hour
- Transition to norepinephrine typically occurs at median 7 hours if higher vasopressor support is needed 1
Important Clinical Considerations
Hemodynamic Stability
Metaraminol maintains stable hemodynamics without causing tachycardia 1. During infusion:
- Heart rate remains stable
- Mean arterial pressure is well-maintained
- Urine output typically stays >30 mL/hour for first 24 hours
- No clinical evidence of tachyphylaxis
Push-Dose Administration
For intubation in septic patients, prophylactic push-dose metaraminol (typically 0.5-2 mg bolus) reduces post-intubation hypotension from 49.4% to 21.1% 3. This can be combined with continuous infusion.
Transition Strategy
Clinicians frequently transition to norepinephrine early (median 7 hours) despite low metaraminol doses 1. Consider switching when:
- Doses approach 4-6 mg/hour
- Patient requires more aggressive vasopressor support
- Underlying shock state worsens
Common Pitfalls
- Underdosing in obese patients: Remember to increase initial dose by ~25% for BMI ≥30 kg/m²
- Premature escalation: Metaraminol is effective at low doses; avoid unnecessary early transition to norepinephrine
- Fixed dosing: Adjust based on patient weight and clinical response rather than using one-size-fits-all approach
The evidence shows metaraminol is particularly useful for less severe hypotension in ICU patients with low illness severity and for preventing spinal anesthesia-induced hypotension in obstetric patients 1, 2.